Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
34.24 USD | -2.49% | -2.97% | +35.60% |
Kurzporträt
Mitarbeiterzahl: 187
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Small Molecule Therapeutics
100,0
%
| 47 | 100,0 % | 79 | 100,0 % | +67.84% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 47 | 100,0 % | 79 | 100,0 % | +67.84% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Nello Mainolfi
FOU | Founder | 45 | 01.09.15 |
Bruce Jacobs
DFI | Director of Finance/CFO | 54 | 15.07.19 |
Juliet Williams
CTO | Chief Tech/Sci/R&D Officer | - | 05.05.21 |
Kevin Dushney
CTO | Chief Tech/Sci/R&D Officer | - | 03.02.21 |
Jared Gollob
CTO | Chief Tech/Sci/R&D Officer | 60 | 01.09.18 |
Vijay Sabesan
CTO | Chief Tech/Sci/R&D Officer | 51 | 06.12.21 |
Jeremy Chadwick
COO | Chief Operating Officer | 61 | 22.05.23 |
Investor Relations Contact | - | 01.07.23 | |
Aimee Mishkin
LAW | General Counsel | - | 01.04.20 |
Melissa Brody
PRN | Corporate Officer/Principal | - | 02.11.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 28.03. |
Joanna Horobin
BRD | Director/Board Member | 69 | 01.05.18 |
John Maraganore
BRD | Director/Board Member | 60 | 17.01.22 |
Elena Ridloff
BRD | Director/Board Member | 44 | 12.03.21 |
Bruce Booth
FOU | Founder | 49 | 01.04.16 |
Pamela Esposito
BRD | Director/Board Member | 50 | 04.09.20 |
Jeffrey Albers
BRD | Director/Board Member | 52 | 01.07.20 |
Leigh Morgan
BRD | Director/Board Member | - | 08.07.22 |
Victor Sandor
BRD | Director/Board Member | 57 | 03.11.22 |
Nello Mainolfi
FOU | Founder | 45 | 01.09.15 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 61 111 678 | 60 268 601 ( 98,62 %) | 0 | 98,62 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+35.60% | 2.15 Mrd. | |
-2.04% | 41.35 Mrd. | |
+42.15% | 40.38 Mrd. | |
+1.48% | 39.05 Mrd. | |
-14.19% | 26.67 Mrd. | |
+2.06% | 24.07 Mrd. | |
-24.79% | 18.36 Mrd. | |
-3.57% | 11.68 Mrd. | |
+20.94% | 11.6 Mrd. | |
+7.81% | 11.15 Mrd. |
- Börse
- Aktien
- A2QBSH Aktie
- Unternehmen Kymera Therapeutics, Inc.